Price T Rowe Associates Inc. MD Acquires 2,807 Shares of Varex Imaging Co. (NASDAQ:VREX)

Price T Rowe Associates Inc. MD grew its holdings in shares of Varex Imaging Co. (NASDAQ:VREX) by 22.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,411 shares of the company’s stock after purchasing an additional 2,807 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Varex Imaging were worth $225,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in VREX. Empowered Funds LLC boosted its position in Varex Imaging by 5.1% during the fourth quarter. Empowered Funds LLC now owns 166,977 shares of the company’s stock worth $2,436,000 after purchasing an additional 8,104 shares during the period. Savant Capital LLC bought a new position in Varex Imaging during the fourth quarter worth about $237,000. Principal Financial Group Inc. boosted its position in Varex Imaging by 10.5% during the fourth quarter. Principal Financial Group Inc. now owns 41,144 shares of the company’s stock worth $600,000 after purchasing an additional 3,914 shares during the period. Rice Hall James & Associates LLC boosted its position in Varex Imaging by 240.7% during the fourth quarter. Rice Hall James & Associates LLC now owns 328,692 shares of the company’s stock worth $4,796,000 after purchasing an additional 232,229 shares during the period. Finally, New York State Common Retirement Fund boosted its position in Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company’s stock worth $139,000 after purchasing an additional 3,600 shares during the period.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. StockNews.com raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a report on Friday, February 7th. B. Riley raised shares of Varex Imaging to a “strong-buy” rating in a report on Monday, May 12th. Finally, Oppenheimer lowered their price target on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a report on Friday, February 7th.

Insider Buying and Selling at Varex Imaging

In other Varex Imaging news, CEO Sunny Sanyal sold 8,749 shares of Varex Imaging stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total transaction of $98,338.76. Following the transaction, the chief executive officer now directly owns 190,193 shares of the company’s stock, valued at approximately $2,137,769.32. This trade represents a 4.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Kimberley E. Honeysett sold 4,007 shares of Varex Imaging stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now directly owns 4,002 shares in the company, valued at $51,265.62. This trade represents a 50.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by company insiders.

Varex Imaging Trading Down 0.1%

Shares of Varex Imaging stock opened at $7.88 on Friday. Varex Imaging Co. has a 1 year low of $6.76 and a 1 year high of $16.93. The firm has a market cap of $324.66 million, a PE ratio of -6.73 and a beta of 0.62. The company has a debt-to-equity ratio of 1.02, a current ratio of 4.36 and a quick ratio of 2.50. The company has a 50 day simple moving average of $9.36 and a two-hundred day simple moving average of $12.53.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Thursday, May 8th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The business had revenue of $212.90 million during the quarter, compared to analyst estimates of $206.76 million. During the same period in the previous year, the business posted $0.16 earnings per share. Varex Imaging’s revenue for the quarter was up 3.3% on a year-over-year basis. Analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.